Is bare-metal stenting of large coronary arteries in ST-elevation myocardial infarction associated with low rates of target vessel revascularization?
Bare-metal stent deployment in STEMI patients with IRAs ≥3.5 mm was associated with low rates of TVR. Their use in this setting warrants comparison with second-generation drug-eluting stenting deployment in future randomized clinical trials.
IL21 is overproduced in the mucosa of CD patients, where it helps sustain T-bet expression and IFNgamma production.